Unlocking Nature’s Pharmacy: How Obakulactone Targets ACOT1 to Rewrite the Future of Rheumatoid Arthritis Therapy
Executive Overview Rheumatoid arthritis (RA) remains one of modern medicine’s most stubborn adversaries—a chronic, systemic autoimmune condition affecting approximately 1%...
